09:56 AM EST - Abattis Bioceuticals Corp. : Announced the addition of three new vaporizers to its product line. Since the Company’s acquisition of Green Tree Therapeutics earlier this year, Abattis has been working to expand its retail presence and product line and is now ready to release its first three vaporizers, the VB-1, VB-2 and the KB-1. Abattis Bioceuticals Corp.
shares ATT:CNX are trading up 1 cent at $0.21.
